Clinical Trial Update: Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD) [Phase 3]

View source ↗

Summary

A Phase 3 trial reports tolerability and efficacy of high-dose escitalopram for obsessive-compulsive disorder. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Abarbanel Mental Health Center | Conditions: Obsessive-Compulsive Disorder | Phase 3 | Status: COMPLETED